Recombinant human erythropoietin treatment of chronic renal failure patients normalizes altered phenotype and proliferation of CD4-positive T lymphocytes

Artificial Organs

Volumn 34, Issue 3, 2010, Pages

  Lisowska, Katarzyna A ^a,b   Debska Slizien, Alicja ^a   Radzka, Monika ^a   Witkowski, Jacek M ^b   Rutkowski, Boleslaw ^a   Bryl, Ewa ^b  

^a Department of Nephrology Transplantology and Internal Diseases   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Antigens; Hemodialysis; Recombinant erythropoietin

Indexed keywords

ANTIGENS; CHEMICAL ACTIVATION; CYTOLOGY; NUMERICAL METHODS; PATIENT TREATMENT;

CD4 T-LYMPHOCYTES; CHRONIC RENAL FAILURE; HAEMODIALYSIS; HEALTHY CONTROLS; HUMAN ERYTHROPOIETIN; IMMUNOMODULATORY; IMMUNOMODULATORY EFFECTS; IN-VITRO; RECOMBINANT ERYTHROPOIETIN; T LYMPHOCYTES;

T-CELLS;

BIOLOGICAL MARKER; CD28 ANTIGEN; CD69 ANTIGEN; FAS ANTIGEN; HLA DR ANTIGEN; RECOMBINANT ERYTHROPOIETIN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CELL KINETICS; CELL PROLIFERATION; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MALE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 77949662708     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2009.00942.x     Document Type: Article

References (25)

1. Herbelin A, Nguyen AT, Urena P, Zingraff J, Descamps-Latscha B. Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor. Kidney Int 1990 37 : 116 125.
2. Cavaillon JM, Poignet JL, Fitting C, Delons S. Serum of interleukin-6 in long-term hemodialysis patients. Nephron 1991 60 : 307 313.
3. Herbelin A, Urena P, Zingraff J, Descamps-Latscha B. Influence of first long-term dialysis on uremia-associated increased basal production of interleukin-1 and tumor necrosis factor α by circulating monocytes. Nephrol Dial Transplant 1991 6 : 349 357.
4. Revillard JP. Immunological alterations in chronic renal failure insufficiency. Adv Nephrol 1979 8 : 365 382.
5. Chatnoud L, Dugas B, Beaurain G, et al. Presence of preactivated T cells in hemodialyzed patients: their possible role in altered immunity. Proc Natl Acad Sci USA 1986 83 : 7457 7461.
6. Allegra V, Vasile A, Maschio M, Mengozzi G. Immune response after vaccination with recombinant hepatitis surface antigen in maintenance hemodialysis patients and healthy control. Nephron 1992 61 : 339 340.
7. Andrew OT, Shoenfeld PY, Hopewell C, Humphreys MH. Tuberculosis in patients with end-stage renal disease. Am J Med 1980 68 : 59 65.
8. Girndt M, Sester M, Sester U, Kaul H, Kohler H. Molecular aspects of T- and B-cells in uremia. Kindey Int 2000 59 : 202 211.
9. Shapiro VS, Truitt K, Imboden JB, Weiss A. CD28 mediates transcriptional upregulation of the Interelukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites. Mol Cell Biol 1997 17 : 4501 4508.
10. Bryl E, Vallejo AN, Weyand CM, Goronzy JJ. Down-regulation of CD28 expression by TNF-alpha. J Immunol 2001 167 : 3231 3238.
11. Beaurain G, Naret C, Marcon L, et al. In vivo T cell preactivation in chronic uremic hemodialyzed patients and non-hemodialyzed patients. Kidney Int 1989 36 : 636 644.
12. Tetta C, Camussi G, Turello E, et al. Production of cytokines in hemodialysis. Blood Purif 1990 8 : 337 346.
13. Bryl E, Mysliwska J, Debska-Slizien A, et al. Recombinant human erythropoietin stimulates production of interleukin 2 by whole blood cell cultures of hemodialysis patients. Artif Organs 1999 23 : 809 816.
14. Bryl E, Mysliwska J, Debska-Slizien A, et al. The influence of recombinant human erythropoietin on tumor necrosis factor α and interleukin 10 production by whole blood cell cultures of hemodialysis patients. Artif Organs 1998 22 : 177 184.
15. Itoh K, Hirohata S. The role of IL-10 in human B cell activation, proliferation and differentiation. J Immunol 1995 154 : 4341 4350.
16. Kimata H, Yoshida A, Ishioka C, Masuda S, Sasaki R, Mikawa H. Human recombinant erythropoietin directly stimulates B cells immunoglobulin production and proliferation in serum-free medium. Clin Exp Immunol 1991 85 : 151 156.
17. Buemi M, Allegra A, Aloisi C, Frisina N. Influence of therapy with recombinant erythropoietin on serum levels of neopterin in hemodialysis subjects. Am J Nephrol 1991 11 : 281 283.
18. Hasbold J, Gett AV, Rush JS, et al. Quantitative analysis of lymphocyte differentiation and proliferation in vitro using carboxyfluorescein diacetate succinimidyl ester. Immunol Cell Biol 1999 77 : 516 522.
19. Witkowski JM. Advanced application of CFSE for cellular tracking. Curr Protoc Cytom 2008 Chapter 9: Unit 9.25:1-9.
20. Jelkmann W, Metzen E. Erythropoietin in the control of red cell production. Ann Anat 1996 178 : 391 403.
21. Ziegler SF, Ramsdell F, Alderson MR. The activation antigen CD69. Stem Cells 1994 12 : 456 465.
22. Jumper MD, Splawski JB, Lipsky PE, Meek K. Ligation of CD40 induces sterile transcripts of multiple Ig H chain isotypes in human B cells. J Immunol 1994 152 : 438 445.
23. Jabara HH, Fu SM, Geha RS, Vercelli D. CD40 and IgE. synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J Exp Med 1990 172 : 1861 1864.
24. Schaefer RM, Paczek L, Berthold G, Gilge U, Heidland A. Improved immunoglobulin production in hemodialysis patients treated with recombinant erythropoietin. Int J Artif Organs 1992 15 : 204 208.
25. + lymphocytes: a role for a cyclin D1 and calpain. Exp Gerontol 2004 39 : 577 585.